|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Hepatitis C Virus (HCV) - Market Insights, Epidemiology, and Market Forecast - 2030 ... ; dasabuvir tablets), and Zepatier (elbasvir/grazoprevir) are the DAAs ... Oral antiviral medications include Zepatier (elbasvir and grazoprevir), Harvoni (ledipasvir ... direct-acting antiviral treatments. Also, Elbasvir–grazoprevir was recommended by NICE, ... Hepatitis C: KOL Insight ... / ombitasvir/ dasabuvir; AbbVie/Enanta) Zepatier (elbasvir/grazoprevir; Merck & Co.) Plus 9 more – download ... Global Pharma US & EU Outlook 2015: First –In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition In the recent years several new therapies have been approved in the area of ... Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have ... Global Hepatitis Drugs Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023 Overview: Hepatitis is a medical condition where the liver is predominantly affected, which can also affect the digestive system and brain. There are three major types of hepatitis condition – HAV, HBV, and HCV. HCV is a major public health problem that ... NPS+ Hepatitis C Virus (HCV) Infection US [2018] ... (ombitasvir/paritaprevir/ritonavir; AbbVie) Zepatier (elbasvir/grazoprevir; Merck & Co.) Explore Important Brand ... NPS+ Hepatitis C Virus (HCV)Infection (EU5) [2018] ... (ombitasvir/paritaprevir/ritonavir; AbbVie) Zepatier (elbasvir/grazoprevir; Merck Sharp & Dohme) Explore ... Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. 'Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts' presents an in-depth assessment of the global ... Viral Hepatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major viral hepatitis markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The viral hepatitis market has been comprehensively analyzed in IMARC's new report titled "Viral Hepatitis Market: Epidemiology, Industry Trends, Share, Size, ... Innovative drugs: Mapping the pricing, reimbursement and HTA landscape ... Deflazacort Delafloxacin Dupilumab Durvalumab Edaravone Elbasvir/Grazoprevir Elotuzumab Eluxadoline Enasidenib Etelcalcetide ... Hepatitis C: Update Bulletin [February 2016] ... KOL insights on how Merck & Co.’s Zepatier (elbasvir and grazoprevir) is likely to be used as a treatment ... : How do KOLs expect Merck & Co.’s Zepatier (elbasvir and grazoprevir) to be received in the marketplace ... |